Pages
(Move to ...)
Home
Northwell Nephrology Fellowship
The Galdi Fellowship(GN-Onconephrology)
Concept Maps
Detective Nephron Series(ASN Kidney News)
Teaching Resources
Journals
Society Links
Cases/Quiz
Crosswords
GN Chat
Anagrams
GNin10 Podcasts( ISGD)
About
▼
Take a look here
(Move to ...)
Home
About
Journals
Non renal Blogs of interest
Society Links
Teaching Resources
Crosswords
Anagrams
Cases/Quiz
Board Preparation
Neph JC
Nephrology Fellowship
Concept Maps
Detective Nephron Series(ASN Kidney News)
▼
Thursday, November 24, 2016
Topic Discussion: Novel anticoagulants in CKD and ESRD
›
New Oral Anticoagulants(NOACs) Renal clearance of parent drug Dosage in ESRD GFR 15-29ml/min GFR 30...
1 comment:
Wednesday, November 9, 2016
TOPIC DISCUSSION: Is THSD7A the paraneoplastic marker for Membranous GN associated with cancer?
›
Two recent papers from Germany have now associated the thrombospondin type 1 domain containing 7A(THSD7A) as a target antigen identified in...
Tuesday, November 8, 2016
Topic Discussion: Serology based treatment of Membranous GN
›
Gone are the days of a kidney biopsy for Membranous GN… Can that happen? Given the advent of PLAR2 antibody titers availability clinicall...
Tuesday, October 25, 2016
Topic Discussion: AKI following LVAD
›
Left ventricular assist devices (LVADs) are used increasingly as a bridge to transplantation or as destination therapy in end-stage heart ...
Wednesday, October 12, 2016
Nephrology Crosswords: Hypertension
›
Next installment of Nephrology Crosswords appears in Kidney International in the Nov 2016 issue. http://www.kidney-international.org/arti...
Tuesday, October 4, 2016
In the NEWS: Lung Ultrasound and volume assessment in ESRD
›
Your new device- the lung ultrasound has made its way in Europe. A recent trail in CJASN discusses the value of using lung ultrasound i...
1 comment:
Monday, October 3, 2016
Concept Map: Electrolyte Disorders and anti cancer agents
›
Most electrolytes disorders are "hypo" that are drug induced from anti cancer agents. Mechanism is mentioned whe...
‹
›
Home
View web version